Anavex Provides Corporate Update, Announces Completion of Clinical Conduct of ADME and DDI Clinical Studies Life Science Investing
TEZSPIRE® DELIVERED HISTOLOGIC REMISSION AND SYMPTOM IMPROVEMENT IN EOSINOPHILIC ESOPHAGITIS Life Science Investing
NanoViricides' Revolutionary Broad-Spectrum Drug Candidate NV-387 Has Successfully Demonstrated Excellent Indications for Safety and Toxicology in a Juvenile Mouse Pups Animal Study, Paving the Way for Pediatric Use in Clinical Trials Life Science Investing
Pliant Therapeutics Appoints Craig Blanchette, Ph.D., as Senior Vice President, Research Life Science Investing
AGCO and Agility Robotics Advance Smart Manufacturing with Humanoid Robot Pilot in Hesston, Kansas, Facility Life Science Investing
Yakira Capital Management Calls on Atrium Therapeutics to Launch Strategic Review, Curb Cash Spending and Explain Dilutive Financing Life Science Investing
Harmony Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026 Life Science Investing
Pliant Therapeutics Announces Upcoming Presentation at European Society for Medical Oncology Congress 2026 Life Science Investing
NRx Pharmaceuticals Announces Completion of Manufacturing Process Validation and Two-Year Stability of Preservative-Free Ketamine Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
